Omini
Paris
About Omini
Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers. It provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Grant (Jul 2024)
- Website: ominilabs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/omini-46300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.